In less than four days in June 2018, the Chinese movie Dying to Survive made ¥1.2 billion ($180 million) at the box office, surpassing the first-week sales record the patriotic action film Wolf Warrior 2 set in 2017. The satirical comedy about a group of cancer patients and a businessperson trying to smuggle low-cost generic drugs from India clearly resonated with the Chinese people, who regularly struggle to get the medicine and health care they need. As the public flocks to theaters, China’s broken health care system has entered public debate, and the government has rushed to respond with a commitment toward regulating drug prices. But –as governments all over the world can attest – fixing a health system is no easy task. In this article featured on finance author Wu Xiaobo’s WeChat wemedia account, writer Ba Jiu Ling stresses that the problem with China’s health care system goes beyond the pricing of drugs. getAbstract recommends this article to health care policymakers, executives in the pharmaceutical industry and anyone interested in health care systems around the world.
About the Author
Ba Jiu Ling is staff writer for Wu Xiaobo’s Channel, a WeChat wemedia account run by business opinion leader and finance author Wu Xiaobo.